$124
Defective Drug
Case results reflect publicly available information reported by the listed law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers.
Case Details
The U.S. Supreme Court refused to hear an appeal from Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson and maker of the anti-psychotic drug, Risperdal. The company has been penalized $124 million by a South Carolina court after finding the drug maker had improperly marketed the drug Risperdal. This verdict is the largest drug marketing award in South Carolina state history and the largest penalty levied for violation of the South Carolina Unfair Trade Practices Act.